Disclosure Policy
It is the policy of the West Virginia University (WVU) School of Medicine Office of Continuing Medical Education (CME) to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in our programs are expected to disclose any relevant relationships they may have with commercial companies. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of WVU School of Medicine Office of CME.
Faculty Disclosure Declarations
John Pellock, MD has a financial interest/relationship in the form of: Advisory Board, Consultant, Lecturer and Researcher for the following: Abbott Laboratories, Cephalon, Eisai, GlaxoSmithKline, MedPointe, Novartis, OrthoMcNeil, Ovation, Pfizer, Questcor, Schwarz Pharma, UCB Pharma, and Valeant Consultant and Lecturer for the following: Accorda, AstraZeneca, Aventis, and CoSensys
Advisory Board and Consultant for: Marinus Pharmaceuticals
James Wheless, MD, has a financial interest/relationship in the form of:
Grant/research support from the following: Abbott Laboratories, Cyberonics, UCB Pharma, NIH, Ovatio
Consulting for the following: Questcor, Novartis, Ortho-McNeil, Abbott Laboratories, Ovation
Speaker for the following: Novartis, Ortho-McNeil, Cyberonics, UCB Pharma
Patricia Dean, MSN, ARNP has a financial interest/relationship in the form of:
Speaker/Advisory Board for UCB Pharma, Content Reviewer/Speaker for Novartis, Advisory Board for Ortho-McNeil and Speaker for GlaxoSmithKline.
Terry Ann Glauser, MD has a financial interest/relationship in the form of:
Payment from Johnson and Johnson Healthcare Systems Inc.
|